Manske Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69M Sell
35,676
-573
-2% -$51.1K 0.92% 19
2026
Q1
$2.6M Sell
36,249
-280
-0.8% -$21.6K 0.73% 29
2025
Q4
$2.9M Sell
36,529
-381
-1% -$30K 0.86% 25
2025
Q3
$2.78M Sell
36,910
-1,393
-4% -$95.5K 0.85% 22
2025
Q2
$2.64M Buy
38,303
+5,213
+16% +$342K 0.87% 23
2025
Q1
$2.24M Buy
33,090
+3,449
+12% +$206K 0.85% 27
2024
Q4
$1.33M Buy
+29,641
New +$1.66M 0.53% 37

Other funds holding CVS

Manske Wealth Management's CVS Position: Q2 2026 in Review

Manske Wealth Management reduced its CVS Health (CVS) stake by 1.6% in Q2 2026, selling an estimated $51.1K and leaving 35,676 shares worth $3.69M. The position accounts for 0.92% of the portfolio, ranked #19.

Manske Wealth Management first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Manske Wealth Management held 35,676 shares of CVS Health worth $3.69M as of Q2 2026.
  • Manske Wealth Management sold 573 CVS Health shares in Q2 2026, an estimated $51.1K.
  • CVS Health made up 0.92% of Manske Wealth Management's portfolio in Q2 2026, its #19 holding.
  • Manske Wealth Management first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.